🇺🇸 FDA
Patent

US 6824976

Method for selective inactivation of viral replication

expired A61KA61K48/00

Quick answer

US patent 6824976 (Method for selective inactivation of viral replication) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K48/00